// company-profile
Aligos Therapeutics, Inc.
ALGSExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings52Insiders14
// api This Aligos Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
No insider activity recorded for ALGS in the last 90 days.
Institutional Ownership
Top 13F-HR holders of Aligos Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$20.4M
QoQ change
-21.4%
Reporting period
2026-03-31
#1
Deep Track Capital, LP
CIK 1856083
$3.3M
444K shares
#2
Alyeska Investment Group, L.P.
CIK 1453072
$3.1M
412K shares
#3
Sio Capital Management, LLC
CIK 1482416
$2.4M
327K shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | BLATT LAWRENCE | ALGS | Award | 105,840 | $0.00 | $0K |
| Mar 9, 2026 | Calhoun Lesley Ann | ALGS | Award | 37,485 | $0.00 | $0K |
| Mar 9, 2026 | Symons Julian A. | ALGS | Award | 23,310 | $0.00 | $0K |
| Mar 9, 2026 | Aneja Nikhil | ALGS | Award | 9,450 | $0.00 | $0K |
| Jul 16, 2025 | Symons Julian A. | ALGS | Award | 16,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.